Neo-Mercazole (Carbimazole)

Carbimazole is converted in the body to methimazole, which blocks thyroid peroxidase. This enzyme is essential for adding iodine to tyrosine residues and coupling them to form T3 and T4. By inhibiting these steps, carbimazole reduces the synthesis of active thyroid hormones, thereby decreasing the excessive hormonal activity seen in hyperthyroid states.

The dose of Neo-Mercazole is individualized by the prescribing clinician based on the severity of the thyroid condition, patient age, weight, and laboratory results. The prescriber determines the appropriate starting dose and any subsequent adjustments, so patients should follow the specific instructions provided by their healthcare professional.

Safety data for carbimazole in pregnancy are limited, and the drug should only be used when the potential benefit to the mother outweighs any possible risk to the fetus. Breastfeeding mothers should discuss use with their physician, as carbimazole can be excreted in breast milk and may affect the infant's thyroid function.

To request Neo-Mercazole, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, and will ask for trade or institutional credentials. The sales team then replies with pricing, availability, shipping details (including any cold‑chain requirements), and the necessary import documentation.

Carbimazole (Neo-Mercazole) belongs to the thionamide class, similar to propylthiouracil (PTU). Compared with PTU, carbimazole generally has a more favorable side‑effect profile, especially regarding liver toxicity, and is often preferred for long‑term management. Both drugs inhibit thyroid hormone synthesis, but carbimazole is usually administered once daily, whereas PTU may require multiple daily doses.

Neo-Mercazole should be stored at room temperature, below 25 °C. Keep the tablets in the original packaging to protect them from moisture and light. Do not store in humid areas such as bathrooms, and keep out of reach of children.

Neo-Mercazole is taken orally, usually with a glass of water. It can be taken with or without food, but patients should follow the prescribing physician’s guidance on timing relative to meals to minimize gastrointestinal discomfort.

The most serious adverse events include agranulocytosis, a potentially life‑threatening drop in white blood cells, and severe liver injury. Patients should promptly report symptoms such as fever, sore throat, jaundice, or unusual fatigue, and clinicians may order regular blood monitoring to detect these complications early.

Neo-Mercazole is contraindicated in individuals with known hypersensitivity to carbimazole or methimazole, and in patients with a history of severe bone‑marrow suppression. Caution is also advised for those with pre‑existing liver disease, and it should be avoided during the first trimester of pregnancy unless absolutely necessary.